This category covers the design, qualification, operation, and lifecycle control of pharmaceutical water systems. It addresses water quality categories, USP requirements, system design and distribution, monitoring programs, and requalification practices required to ensure consistent water quality for intended GMP use.
Pharmaceutical water systems require ongoing lifecycle control to maintain a sustained state of compliance. Initial qualification establishes baseline capability, but continued control is demonstrated through structured monitoring, change control, periodic review, and justified requalification activities. Lifecycle control ensures that water…
Pharmaceutical water systems are direct-impact GMP utilities and must be qualified using a structured, risk-based approach. Qualification activities must demonstrate that the system, as installed and operated, can reliably produce water meeting defined quality requirements at all points of use…
United States Pharmacopeia (USP) establishes compendial quality requirements for pharmaceutical waters and defines the analytical framework used to demonstrate compliance. Specifications are not optional targets. They are mandatory acceptance criteria that must be met at the point of use and…
Pharmaceutical water systems must be intentionally engineered to consistently deliver water that meets its defined quality attributes at the point of use. Design and distribution are not aesthetic or convenience decisions. They are primary control mechanisms that determine whether the…
Pharmaceutical water is a manufactured GMP material produced on site under controlled conditions. It is governed by pharmacopeial requirements and regulatory expectations in the same manner as other critical raw materials. Water quality selection is not discretionary. It is dictated…